Brain Cancer Archives - Cancer Therapy Advisor

Researches took a critical look at noninferiority trials and determined that when a new intervention is “not worse,” the possibility exists that it is not better, either.

Knowing the Appropriateness of Running Noninferiority Trials in Oncology

By

Randi Hernandez

August 30, 2019

Researches took a critical look at noninferiority trials and determined that when a new intervention is “not worse,” the possibility exists that it is not better, either.

Researchers examine how patient outcomes could be affected if patients were to receive systemic drug treatment at dedicated cancer centers versus at community health systems.

General Oncology

Tapping Into the Therapeutic Expertise of High-Volume Cancer Centers

By

Charlotte Huff

August 23, 2019

Researchers examine how patient outcomes could be affected if patients were to receive systemic drug treatment at dedicated cancer centers versus at community health systems.

Chemotherapy treatment can affect a patient’s memory or attention span. It is often referred to as “chemo brain.” An individual may suffer from resulting short-term memory loss.8

Brain Cancer

Treatment Reduction in Intermediate-Risk Neuroblastoma Deemed Successful

By

Christina Bennett, MS

August 15, 2019

For specific subsets of patients with intermediate-risk neuroblastoma, an algorithm successfully reduced treatment while maintaining survival outcomes.

The researchers wrote that “genetic counseling must be further explored to find an optimal balance of clinical quality with increased access and financial sustainability.”

General Oncology

New Trial Attempts to Make Genetic Counseling and Testing More Accessible

By

Agata Boxe

August 13, 2019

The researchers wrote that “genetic counseling must be further explored to find an optimal balance of clinical quality with increased access and financial sustainability.”

General Oncology

T-Cell Cryopreservation for Use in Future Cancer Treatment: Hot or Hype?

By

Kristin Bundy

August 12, 2019

Can healthy immune cells from a patient be frozen and used in the future to make adoptive cell therapies in the event of a cancer diagnosis?

Oncologists are changing the way they treat, perhaps too quickly and with too little evidence — but the behavior may signal a bigger problem with how research is reported.

General Oncology

Do Oncologists Change Practice Based on Inadequate Evidence?

By

Christina Bennett, MS

July 31, 2019

Oncologists are changing the way they treat, perhaps too quickly and with too little evidence — but the behavior may signal a bigger problem with how research is reported.